Investor Presentation H1 2023 slide image

Investor Presentation H1 2023

22 22 Investor presentation First six months of 2023 Appendix Novo Nordisk corporate strategy Diabetes care GLP-1 Insulin 23 36 45 53 Obesity care 58 Rare disease 82 Other serious chronic diseases 95 Regional information 113 Financials 143 Sustainability 152
View entire presentation